GlassScriptPhysician profile
Andrew Schneider
NPI 1982600177
$150,172.35
in general payments reported to CMS, 2019-2025
25 companies · $2,776 in 2025
The $2,776 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $60.65 · 2021: $193 · 2022: $124 · 2023: $305 · 2024: $146K · 2025: $2,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $146K · Food and Beverage: $1,835 · Travel and Lodging: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $146,200.00 |
| Food and Beverage | $1,835.44 |
| Travel and Lodging | $1,446.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $146,200.00 | 2024 | |
| Stryker Corporation | $2,282.24 | 2019-2025 | Prostep, Prostep Mica, Augment Injectable |
| Treace Medical Concepts, INC. | $809.45 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $174.93 | 2023-2025 | Nuzyra |
| Grt US Holding, INC. | $99.76 | 2021 | |
| Smith+Nephew, INC. | $68.75 | 2019-2024 | Collagenase Santyl |
| Bioventus LLC | $66.98 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $65.62 | 2022-2023 | Senza |
| Heron Therapeutics, INC. | $59.41 | 2021-2023 | Zynrelef |
| Horizon Therapeutics Plc | $52.94 | 2019-2023 | Krystexxa |
| Medtronic, INC. | $43.15 | 2022-2023 | Intellis Adaptivestim |
| Innovation Technologies INC | $26.07 | 2023 | Irrisept |
| Arthrosurface Incorporated | $25.68 | 2020 | |
| Mimedx Group, INC. | $22.34 | 2025 | |
| Dynasplint Systems INC. | $22.28 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.69 | 2023 | Eterna |
| Zimmer Biomet Holdings, INC. | $20.03 | 2019 | |
| Amniox Medical, INC. | $18.99 | 2020 | |
| Amgen INC. | $18.50 | 2024 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $17.87 | 2021 | |
| Apyx Medical Corporation | $15.98 | 2020 | |
| Argentum Medical | $14.24 | 2023 | |
| Triad Life Sciences INC. | $13.01 | 2022 | |
| Anika Therapeutics, INC. | $12.44 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.